Healthcare growth that keeps its margin.

Healthcare businesses in India tend to grow in a particular way. A first centre works, and works well, because the founding clinicians are in it every day. A second and third centre open on the same model. Patient volume rises, a corporate tie-up brings in a steady stream of employees, a booking platform adds more, and the revenue chart looks exactly the way investors want it to.

Then someone looks at contribution by centre and by channel and finds that the newest volume carries half the margin of the original, arrives two months later, and needs more clinical staff than planned because utilisation in the new centres hasn't caught up. Meanwhile the GST paid on rent, equipment and software across every centre is sitting in the P&L as cost, because none of it can be claimed back.

None of that is unusual. It's the normal shape of the sector, and it's manageable once it's visible. Shafneed spent four years inside a healthcare business, joining at an early stage and leaving from its founding team, which is where most of the patterns on this page come from. The examples below are illustrative, not that company's figures.

Health care services provided by a clinical establishment, an authorised medical practitioner or paramedics are exempt from GST. For patients that's good news. For the business, it means no GST is charged on those services, so there's no output tax to set input tax credit against. The GST you pay on rent, medical equipment, software, marketing and professional fees becomes part of your costs.

That changes the maths of almost every decision. A new centre's fit-out, a software subscription, a booking platform's commission: each one costs its price plus the GST on it, permanently.

Nearly ₹1 lakh a month, per centre, that a taxable business of the same size would have recovered. Across a ten-centre network that's over a crore a year of cost that a generic financial model, built on the assumption that GST washes through, will simply leave out.

It gets more involved when a business provides both exempt and taxable services. Non-clinical support services, some wellness and cosmetic offerings, and fees charged by a healthtech platform are generally taxable, commonly at 18%, and a business with both kinds of supply has to apportion the credit on shared inputs between them under the GST rules. Getting that apportionment wrong is a common source of notices, and a common finding in due diligence.

An illustrative outpatient clinic with a list consultation fee of ₹800. The doctor is paid 45% of the list fee. Other variable costs, including consumables and payment charges, come to about ₹40 a visit. Figures are invented to show the pattern.

All three consultations look the same in a patient-volume report. The corporate and platform visits contribute a little over half of a walk-in, and the corporate cash arrives a quarter later. A clinic whose growth comes mostly from those two channels can double its patient count and see its cash position get worse.

That doesn't make those channels wrong. Corporate tie-ups fill quiet hours, and a platform can be the cheapest way to reach new patients who then return directly. The point is to know the contribution and the cash timing of each, and to decide on purpose how much of the business should depend on them.

Expansion is where healthcare businesses most often get the numbers wrong, and usually in the same direction. The plan for a new centre borrows the revenue of the best existing one, assumes it gets there in six months, and budgets the fit-out and equipment without the GST on them.

The better starting point is your own history. How many months did each existing centre take to reach break-even at contribution level? What did utilisation look like in month three, month six and month twelve? How much of the first year's volume came from the founding clinicians' existing patients, which a new city won't have? Those answers, grouped by centre and opening date, give a ramp curve that is honest about the business you actually run.

Then the cash test. A centre that takes fourteen months to break even needs funding for its losses through that period, on top of the fit-out and deposits. Two openings in the same quarter can make a comfortable runway uncomfortable very quickly, even when both centres eventually do well.

A cash patient pays at the counter. An insurer or third-party administrator pays after the claim is processed, often weeks later, and sometimes pays less than billed once deductions and disallowances are applied. Corporate tie-ups invoice monthly and pay on their own cycle. Government scheme payments have their own timelines.

So two healthcare businesses with the same revenue can have very different cash needs, depending entirely on payer mix. Track receivable days and the deduction rate by payer every month, and treat a rising share of slow payers as a funding decision, not just a sales win.

Deductions deserve their own line in the MIS. A claim billed at ₹50,000 and settled at ₹44,500 isn't a collection delay. It's an 11% price cut that nobody approved, and if it's repeated across hundreds of claims it quietly becomes one of the biggest numbers in the business.

Not every health startup delivers care. Software for hospitals and clinics, marketplaces connecting patients to providers, and care-coordination or subscription models each have their own economics, and borrowing a clinic's metrics for them misleads.

• ·Software sold to hospitals: long sales cycles, implementation effort that's easy to under-cost, and slow payment from large institutions. Model receivable days honestly, not at contract terms.
• ·Marketplaces: the take rate is your revenue, not the gross booking value, and GST on your commission is normally taxable. Report gross bookings if you like, but never let them stand in for revenue in an investor pack.
• ·Care-coordination and managed services: often a mix of exempt and taxable supplies, which makes the GST structure a design decision to settle with your CA early, not a year-end tidy-up.
• ·Subscription and membership models: retention by cohort is the whole story, and the first three months usually decide it.

The work is the same work Simplify does for any founder, shaped around how healthcare actually earns. A unit economics review by service line, centre and payer. A fundraising model built on centre cohorts instead of a single growth rate. Monthly MIS with a P&L by centre. A cash forecast that knows insurance and corporate receipts take longer than walk-ins. An operating plan that treats each new centre's ramp as a real cost.

Clinical, regulatory and legal questions sit with the right specialists. Tax treatment decisions sit with your CA. What Simplify brings is the finance judgement that connects them to the decisions you're making.